Sanofi-Aventis

...University in Brisbane, Australia, while tests for the other two diseases will take place at the Institut Pasteur Korea" (DeArment, 11/18). Sanofi-Aventis, Medicines for Malaria Venture To Launch Study Of Antimalarial Drug

In this article: Drugs for Neglected Diseases Initiative, Pfizer, Malaria, Chagas disease, Visceral leishmaniasis, Sleeping sickness, Medical advice, African trypanosomiasis, and Amodiaquine

...-- French drugmaker Sanofi-Aaventis /quotes/comstock/24s!e:san (FR:SAN 51.06, -0.44, -0.85%) /quotes/comstock/13*!sny/quotes/nls/sny (SNY 38.42, -0.05, -0.13%) and Medicines for Malaria Venture will launch the largest safety and...

In this article: Amodiaquine, Artesunate, MarketWatch, and London

...Plavix's labeling to advise against using it in combination with certain heartburn drugs. A Sanofi spokeswoman said Tuesday that the company has bolstered that language labeling. "We've strengthened the label to say that these drugs...

In this article: Clopidogrel, Food and Drug Administration, Heartburn, Nexium, Prilosec, Bristol-Myers Squibb, Mylanta, and Zantac

LONDON (MarketWatch) -- Sanofi-Aventis /quotes/comstock/24s!e:san (FR:SAN 51.43, +0.26, +0.51%) /quotes/comstock/13*!sny/quotes/nls/sny (SNY 38.22, +0.26, +0.68%) Monday that the French drug agency Afssaps has granted marketing...

In this article: France, Influenza A, MarketWatch, and London

by: The Burrill Report November 15, 2009 | about: REGN / SNY Chris Viehbacher, CEO of Sanofi-Aventis (SNY), said his company will establish a venture capital fund, joining an ever-growing queue of pharma venture capital funds seeking to...

In this article: Regeneron, Venture capital, Venture Capital Fund, United States, Revenue, Time horizon, and Cancer

"The eggs are a perfect little factory for the vaccine," said Sam Lee, director of manufacturing technology for Sanofi Pasteur. Sanofi uses more than a million a week to grow the vaccine as 2,000 of its 3,200 employees rush to make the H1N1...

In this article: Sanofi, Legal age, CSL Ltd., MedImmune Inc, Novartis AG, and United States

...a sustainable business. (Viehbacher spoke to Xconomy at length in June about his strategy for building sustainable business at Sanofi.) Sanofi has been in Massachusetts for more than a decade, but the company has been less active in...

In this article: Boston, Clopidogrel, Zolpidem, Cambridge, MA, Venture capital, and Cancer

...details) NEW YORK, Nov 10 (Reuters) - Regeneron Pharmaceuticals Inc <REGN.O> and French drugmaker Sanofi-aventis <SASY.PA> said on Tuesday they have expanded their partnership to develop a number of Regeneron's experimental drugs. Sanofi...

In this article: Regeneron, Cancer, NEW YORK, Macular degeneration, Lung cancer, and Nasdaq

...end in 2012. Under the expanded deal, the companies plan on advancing up to five antibodies into clinical development each year, with Sanofi-Aventis funding up to $160 million annually for Regeneron research until the end of 2017 - up from...

In this article: Regeneron, Rheumatoid arthritis, Paris, and NEW YORK

* 75 mln H1N1 vaccine doses to ship in US by Christmas * Sanofi expects first EU H1N1 approval "shortly" (Adds details on vaccine production, pending EU approvals) By Ros Krasny Production of H1N1 swine flu vaccine at two U.S....

In this article: EU, United States, Cambridge, Massachusetts, and Pennsylvania